Michael R. Norman

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

C. Probert, C. Dayan, S. Hearing, 1999, Gut.

Basiliximab (anti‐CD25) in combination with steroids may be an effective new treatment for steroid‐resistant ulcerative colitis

I. S. Shaw, N. Shepherd, M. Moorghen, 2003, Alimentary pharmacology & therapeutics.

Wide variation in lymphocyte steroid sensitivity among healthy human volunteers.

C. Dayan, S. Hearing, C. Smyth, 1999, The Journal of clinical endocrinology and metabolism.